Opportunity
Simpler Grants.gov #PAR-27-049
NIAMS Grant Opportunity for Ancillary Studies to Ongoing Clinical Projects
Buyer
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Posted
June 12, 2025
Respond By
April 06, 2026
Identifier
PAR-27-049
NAICS
541715
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (NIH), is soliciting applications for research grants supporting ancillary studies to ongoing clinical projects. - Government Buyer: - National Institutes of Health (NIH) - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) - Products/Services Requested: - Research services for ancillary studies that utilize resources from ongoing parent clinical studies - Resources may include patient cohorts, infrastructure, data, and biological samples - Studies must align with the NIAMS mission, even if the parent study is outside this mission - OEMs and Vendors: - No specific OEMs or vendors are mentioned, as this is a research grant opportunity - Unique/Notable Requirements: - Open to investigators with expertise in diseases and conditions relevant to NIAMS - Encourages collaborative investigations leveraging clinical research expertise - Eligible applicants include nonprofits, educational institutions, government entities, and businesses - Approximately four awards anticipated, with total program funding of $2,000,000 - Funding Instrument: - Grant (not a contract or product procurement) - Place of Performance: - National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Description
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is soliciting applications for research on ancillary studies that leverage resources from ongoing parent clinical studies, including patient cohorts, infrastructure, data, and biological samples. The ancillary studies should align with the NIAMS mission, even if the parent studies are outside this mission. The notice encourages investigators with expertise in NIAMS-related diseases and conditions to apply, as well as collaborative investigations combining clinical research expertise. The funding opportunity aims to support meaningful collaborations and responsive projects in this area.